AltruBio Raises $63 Million Series A Round to Continue Its Company Transformation
AltruBio Inc., a clinical stage biotech company, has announced the completion of a $63 million Series A financing round led by aMoon with new investors including BVF Partners L.P. (BVF), CAM Capital, and other new and existing investors joining the syndicate. (Photo by CNA: Dr. Judy Chou, AltruBio’s President & CEO)
2021-04-19